Synthia Laura Molina is an expert in industry development, market leadership, and quality systems. She has more than two decades of experience in the health and management education industries, and she currently focuses on value creation at the convergence of the healthcare, information technology, and business-to-business sectors.
Prior to founding Mission Accomplished, Synthia developed strategy, leadership, and general management expertise through progressive positions in quality control, laboratory sciences, quality assurance, regulatory affairs, R&D, marketing research, product development, product management, marketing management, sales, sales management, business development, operations management, and corporate finance. As CEO of ABC Coding Solutions, she secured federal review of the company as the national standard-setting organization for HIPAA-compliant codes representing allied and public health, nursing, complementary and alternative medicine, and other integrative healthcare practices. In the mid-1990s, she directed the Drucker MBA program at the Claremont Colleges and helped the Drucker School achieve even greater national prominence among management education programs. Between 1990 and 1995, she served as Director of Marketing Research and Vice President of Industry and Business Development for HealthIQ, a reimbursement strategy, medical economics, and industry intelligence firm subsequently acquired by Elsevier. In the 1980s, she resolved an international crisis for Baxter Healthcare Corporation and the American Red Cross, involving hundreds of production lots of HIV and Hepatitis-tainted blood products. She led a regulatory affairs, quality systems, and new product development turnaround for Ioptex Research, Inc., prior to its acquisition by Smith & Nephew. She implemented quality engineering programs in the quality control department and science laboratories of a newly acquired Johnson & Johnson subsidiary.
Her consulting engagements have included corporate planning and product/portfolio optimization initiatives for brand name companies (such as Abbott, Amgen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novo Nordisk, Pfizer, and Philips Medical Systems), and for market-transforming information technology and electronic commerce companies (such as Manhattan Associates, WebMD and VeriFone).
An internationally recognized author, lecturer and expert on health industry and corporate evolution, Synthia has spoken at dozens of health industry conferences on topics such as strategic management, product portfolio evaluation and planning, medical economics, outcomes research, health and disease management programs; performance and outcomes-based payment systems, gain-sharing initiatives, health-related data standards, consumer-driven healthcare, health information system interoperability, and social HMOs. She has written dozens of articles in health industry trade publications and is frequently quoted in the press. She earned honors in the premedical science programs at the University of California at Berkeley and Pomona College, holds a BS in management and organizational behavior, and was ranked first in her graduating class at the Peter F. Drucker and Masatoshi Ito Graduate School of Management, near Los Angeles, where she completed her MBA.